RMD Stock Risk & Deep Value Analysis
Resmed Inc
Healthcare • Medical Instruments & Supplies
DVR Score
out of 10
What You Need to Know About RMD Stock
We analyzed Resmed Inc using our deep value framework. Sign in to see our full verdict and DVR Score.
We ran RMD through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Our risk assessment: Moderate. Here's what we found.
How Risky Is RMD Stock?
Overall Risk
Moderate
Financial Risk
Low
Market Risk
Low
Competitive Risk
Medium
Execution Risk
Low
Regulatory Risk
Medium
What Are the Red Flags for RMD?
- ⚠
Major competitor product launch with superior technology or aggressive pricing
- ⚠
Unexpected regulatory changes impacting medical device sales or data privacy
- ⚠
Significant supply chain disruptions affecting component availability or costs
Unlock RMD Red Flags & Risk Warnings
Create a free account to see the full analysis
What Does Resmed Inc (RMD) Do?
Market Cap
$35.73B
Sector
Healthcare
Industry
Medical Instruments & Supplies
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Visit Resmed Inc WebsiteIs RMD Stock Undervalued?
Unlock the full AI analysis for RMD
Get the complete DVR score, risk analysis, and more
Is RMD Financially Healthy?
P/E Ratio
25.03
Does RMD Have a Competitive Moat?
Sign in to unlockMoat Rating
🏰 Wide
Moat Trend
Stable
Moat Sources
4 Identified
ResMed's moat is highly durable due to its continuous investment in R&D, leading to innovative, patented products. Strong brand loyalty among healthcare providers and patients, coupled with high switching costs associated with integrated device ecosystems and patient data, makes it difficult for competitors to displace.
Moat Erosion Risks
- •Emergence of radically new or non-device-based treatment alternatives for sleep apnea.
- •Significant and unfavorable changes in global healthcare reimbursement policies.
- •Successful and sustained innovation by competitors that significantly erodes RMD's technological lead.
RMD Competitive Moat Analysis
Sign up to see competitive advantages
What Could Drive RMD Stock Higher?
Near-Term (0-6 months)
- •Q2 2026 Earnings Report (estimated late April 2026)
- •Launch of next-generation CPAP devices or mask innovations
- •Key regulatory approvals for new therapeutic indications or markets
Medium-Term (6-18 months)
- •Expansion into new geographic markets (e.g., emerging economies)
- •Strategic partnerships to integrate digital health platforms or AI solutions
- •Increased adoption of HME (Home Medical Equipment) SaaS solutions
Long-Term (18+ months)
- •Demographic tailwinds: aging population increasing sleep apnea prevalence
- •Continued integration of AI for personalized therapy and adherence monitoring
- •Industry leadership in value-based care models for chronic respiratory conditions
Catalysts & Growth Drivers
Upgrade to Premium to see catalysts
What's the Bull Case for RMD?
- ✓
Acceleration in subscription-based revenue growth for connected health solutions.
- ✓
Sustained market share gains in key device and mask segments.
- ✓
Successful integration and monetization of AI-powered therapy insights.
- ✓
Any signs of significant margin compression due to competitive pressures or input costs.
Bull Case Analysis
See what could go right with Premium
Compare RMD to Similar Stocks
See how Resmed Inc stacks up against related companies in our head-to-head analysis.
📊 Explore More Stock Analysis
Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential with our AI-powered analysis.
Important Disclaimer – Not Financial Advice
Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided on this page for RMD (Resmed Inc) should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.
All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research, consider your financial situation, and consult with a qualified financial advisor before making any investment decisions.
